Gestational exposure to COVID-19 did not raise risk for ocular abnormalities in newborns
Click Here to Manage Email Alerts
No ocular abnormalities related to COVID-19 were identified in infants born to mothers with COVID-19, according to a Brazilian study.
“The low rate of ocular abnormalities found in this study, likely within the range of anticipated findings in the absence of COVID-19, suggests that there is not a moderate or high increased risk of ocular abnormalities in newborns of mothers with COVID-19,” first author Olívia Pereira Kiappe, MD, MSc, and colleagues said in the study published in JAMA Ophthalmology.
From April 2020 to November 2020, Kiappe and colleagues enrolled newborns from three maternity hospitals in São Paulo in their study looking at ophthalmological manifestations after maternal COVID-19 infection.
Of 165 newborns aged 1 to 18 days, 123 were full term and 42 were preterm.
One baby tested positive within 18 days of delivery, representing horizontal transmission, and five tested positive on the first day of life, possibly representing vertical transmission, the authors said.
“Although the World Health Organization reported no evidence on vertical transmission when infection occurs in the third trimester, our study showed a possible different scenario,” the authors said.
Reverse transcriptase-polymerase chain reaction assays confirmed the diagnosis in both infants and mothers.
Of all the exposed infants, one had retinal vascular tortuosity and venous engorgement, seven presented with retinal hemorrhages, and two had retinopathy of prematurity.
“Given the appearance compatible with postpartum hemorrhages in this study, it is hard to tell whether retinal hemorrhages are secondary to COVID-19 or just incidental findings, since the rate we found (4.2% [7 of 165]) is within the published cross-sectional reports (6.7%). In addition, our study found that two newborns had retinopathy of prematurity. This means a rate of 333% among infants born with weight less than 1,250 g, which is also in line with expected rates of retinopathy of prematurity in COVID-19-naive populations,” the authors said.